What is the current market size?

The Bovine Tuberculosis Diagnosis market size reached USD 1.2 billion in 2023, driven by rising zoonotic disease concerns and government-led surveillance programs.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by advancements in rapid diagnostic technologies and livestock population expansion.

What are the key growth drivers?

Key drivers include increasing dairy and beef consumption, stricter regulatory frameworks, and the adoption of innovative testing methods like qPCR and lateral flow assays.

What challenges hinder market growth?

Challenges include high diagnostic costs, limited infrastructure in developing regions, and cross-reactivity issues with other mycobacterial infections.

Which regions lead the market?

North America and the EU dominate the market, while the Asia-Pacific region shows the highest growth due to expanding livestock farming and government investments.

Who are the top companies?

Leading players include Zoetis, IDEXX Laboratories, Thermo Fisher Scientific, and Idexx, leveraging R&D and strategic partnerships to strengthen their market position.

What future opportunities exist?

Opportunities lie in point-of-care diagnostics, AI-driven data analysis, and global initiatives to eradicate bovine TB in high-risk agricultural economies.

How does technology impact the market?

Technological advancements such as automated ELISA systems and CRISPR-based tests enhance accuracy and efficiency, transforming the Bovine Tuberculosis Diagnosis market future outlook.

What is the regulatory landscape?

Regulatory bodies like the USDA and OIE enforce standardized testing protocols, ensuring quality and compliance across the Bovine Tuberculosis Diagnosis market.

How do emerging economies contribute?

Emerging markets, particularly in Africa and South Asia, drive demand due to growing dairy sectors and international funding for disease control programs.

Bovine Tuberculosis Diagnosis Value Chain Analysis & Forecast Outlook 2033

Bovine Tuberculosis Diagnosis by Application (Personal, Commercial), by Types (Serological Tests, Molecular Diagnostic Tests, Traditional Tests), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Bovine Tuberculosis Diagnosis Market Overview

The Bovine Tuberculosis Diagnosis market encompasses diagnostic tools, tests, and technologies used to detect Mycobacterium bovis in cattle populations, critical for preventing zoonotic transmission and safeguarding food security. As of 2026, the market size is valued at USD 150 million, reflecting robust growth driven by stringent regulatory frameworks, rising livestock diseases, and advancements in molecular diagnostics. The growth outlook remains optimistic, with a projected compound annual growth rate (CAGR) of 7.2% through 2033, underscored by increased demand from dairy and beef industries. Market forecast models highlight industry expansion in high-prevalence regions, supported by government-funded eradication programs and innovations in point-of-care testing.

Loading chart…

Key forces shaping the Bovine Tuberculosis Diagnosis market include the adoption of next-generation sequencing (NGS) for precision diagnostics and regulatory mandates like the USDA’s Johne’s Disease eradication protocols. North America dominates the market due to advanced veterinary healthcare infrastructure, while Asia-Pacific emerges as the fastest-growing region, fueled by expanding dairy cooperatives in India and China. However, challenges such as high test costs and cross-reactivity with other mycobacterial species may temper adoption. Strategic partnerships between diagnostics firms and livestock agencies are expected to accelerate industry expansion, ensuring alignment with global One Health initiatives.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	IDEXX Laboratories, Inc.; PBD Biotech Ltd.; Zoetis; IDvet; Thermo Fisher Scientific Inc.; Enfer Group; AsureQuality Australia Pty Ltd.; Bio-Rad Laboratories, Inc.; Bionote
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Bovine Tuberculosis Diagnosis market is gaining momentum due to the rising prevalence of zoonotic TB outbreaks, which has intensified regulatory mandates for livestock monitoring. Compulsory testing programs in regions like the EU and North America are driving diagnostic adoption to ensure food safety and prevent cross-species transmission.

Advancements in molecular diagnostics, such as PCR-based assays and automated ELISA platforms, are enhancing accuracy and reducing diagnosis time. These innovations align with the industry’s push for rapid, cost-effective solutions to mitigate economic losses from infected herds.

Restraints2 items

High upfront costs of next-generation diagnostic equipment and limited reimbursement frameworks in low-income countries are restricting market penetration. Small-scale farmers, who constitute a significant portion of the livestock sector, often lack resources for advanced testing.

The persistence of conventional tuberculin skin tests (TST) in rural areas due to their simplicity and affordability is slowing the adoption of newer technologies, despite their lower sensitivity and potential for false negatives.

Opportunities2 items

The Bovine Tuberculosis Diagnosis market size is poised to expand with the rise of portable, point-of-care (POC) diagnostic devices. These tools cater to remote and resource-constrained regions, where access to centralized labs remains a challenge.

Emerging markets in South Asia and Sub-Saharan Africa present untapped potential due to growing dairy production and increasing government investments in animal health infrastructure. Strategic partnerships between diagnostic firms and local veterinary networks could accelerate market growth.

Challenges2 items

Fragmented regulatory standards across regions complicate the approval and commercialization of new diagnostics. Harmonizing protocols while maintaining high sensitivity and specificity remains a technical and bureaucratic hurdle.

The growth forecast for the market is tempered by the lack of skilled personnel to interpret complex tests and maintain equipment. Training programs and digital integration, such as AI-driven result analysis, are critical to overcoming this barrier.

Market Segmentation

Loading chart…

Application segmentation in the Bovine Tuberculosis Diagnosis market reflects diverse use cases driving demand. Veterinary testing dominates, fueled by regulatory mandates for herd health management and zoonotic disease prevention. Livestock surveillance constitutes a secondary segment, supporting proactive disease monitoring in high-risk regions. Export compliance testing forms a niche but critical application, driven by international trade regulations requiring TB-free certification. Together, these applications define the Bovine Tuberculosis Diagnosis segmentation, with veterinary testing alone accounting for 55% of market activity due to its role in routine diagnostics and outbreak response.

Types segmentation categorizes solutions into diagnostic tests and vaccination kits, each addressing distinct market needs. Diagnostic tests, including ELISA, interferon-gamma assays, and culture methods, represent the primary revenue driver at 70% of the market, driven by accuracy requirements for TB detection. Vaccination kits, while smaller at 30%, are gaining traction in regions with high endemic prevalence, emphasizing preventive strategies. This Bovine Tuberculosis Diagnosis segmentation highlights the shift from reactive diagnostics to integrated disease management, with diagnostic tests maintaining dominance due to their role in early detection and regulatory compliance.

Bovine Tuberculosis Diagnosis Segmentation Breakdown7 items

Application

Personal

Commercial

Types

Serological Tests

Molecular Diagnostic Tests

Traditional Tests

Regional Insights

Loading chart…

North America leads the bovine tuberculosis diagnosis market growth with a 32% share, driven by advanced diagnostic infrastructure, stringent USDA regulations, and high livestock adoption of molecular testing. Europe follows at 28%, supported by EU-funded eradication programs, robust veterinary ecosystems, and cross-border collaboration for disease control.

Asia Pacific emerges as the fastest-growing region, projected to capture 25% by 2030. Key drivers include expanding dairy industries in India and China, government subsidies for livestock health, and rising awareness of zoonotic risks. Latin America (12%) and Middle East & Africa (13%) show traction via regional livestock expansion, improved farm-to-lab connectivity, and public-private partnerships, though infrastructure gaps temper growth.

Regional Drivers5 items

North America: Regulatory mandates (USDA), AI-driven diagnostics adoption

Europe: Cross-border data sharing, high farm biosecurity standards

Asia Pacific: Dairy modernization, rising FDI in agri-tech

Latin America: Brazil’s cattle exports, satellite tracking for herd monitoring

Middle East & Africa: GCC livestock investments, mobile diagnostic units

The regional forecast underscores Asia Pacific’s potential to challenge North America’s dominance by 2030, fueled by urbanization-driven dairy demand and digital health integration. Strategic investments in low-resource regions will be critical to closing diagnostic equity gaps.

Competitive Landscape

The Bovine Tuberculosis Diagnosis competitive landscape is moderately consolidated, with a mix of established global players and niche regional suppliers. Key market participants leverage product innovation, regulatory approvals, and strategic partnerships to differentiate. Pricing remains a critical lever, particularly in price-sensitive emerging markets, while advanced diagnostic technologies such as PCR-based assays drive competitive advantage. Certifications like ISO 17025 and compliance with OIE standards further shape market positioning. Global firms focus on broad portfolio depth, whereas regional players emphasize localized distribution and cost-optimized solutions.

Strategic priorities include R&D investment in rapid diagnostic platforms, geographic expansion through acquisitions, and collaborations with veterinary networks. Differentiation is achieved via proprietary technologies, such as Enfer Group’s lateral flow assays or Bio-Rad’s automated immunoassay systems. A key challenge is balancing margin pressures from commodity pricing trends in diagnostic reagents with rising compliance costs for regulatory updates. Channel strength in livestock-dense regions and customization of testing protocols for regional TB strains also influence market dynamics.

Competitive Strategies6 items

IDEXX Laboratories, Inc.: Regional expansion in Asia-Pacific for livestock diagnostics

PBD Biotech Ltd.: Vertical integration to reduce supply chain costs in ELISA kits

Zoetis: Innovation pipeline for multiplex PCR-based TB detection platforms

Thermo Fisher Scientific Inc.: OEM tie-ups for diagnostic equipment distribution in emerging markets

Bio-Rad Laboratories, Inc.: Premium pricing for automated TB diagnostic systems

Enfer Group: Partnerships with veterinary labs for rapid lateral flow test adoption

Key Bovine Tuberculosis Diagnosis Companies9 items

IDEXX Laboratories, Inc.

PBD Biotech Ltd.

Zoetis

IDvet

Thermo Fisher Scientific Inc.

Enfer Group

AsureQuality Australia Pty Ltd.

Bio-Rad Laboratories, Inc.

Bionote

Market Ecosystem

The Bovine Tuberculosis Diagnosis ecosystem spans upstream reagent and technology suppliers, midstream diagnostic solution developers, and downstream veterinary and livestock management stakeholders. Value is generated through accurate disease detection, regulatory compliance, and scalable testing solutions that support animal health and food safety objectives.

Raw material/component suppliers — supply reagents, antigens, and consumables for diagnostic test production.

Diagnostic test manufacturers — develop and produce in vitro diagnostic assays and devices for TB detection.

Technology providers — license molecular, serological, or imaging platforms for diagnostic integration.

System integrators — assemble diagnostic kits, software, and hardware into validated testing solutions.

Distributors/channel partners — facilitate market access for veterinary labs and government agencies.

Veterinary diagnostic laboratories — perform TB testing, analyze samples, and issue reports for herd management.

Regulators/standards bodies — establish certification protocols, compliance frameworks, and approval pathways.

Control points reside with regulators dictating approval standards and technology providers driving innovation. Dependency risks include supply chain constraints for specialized reagents and compliance bottlenecks. Low switching costs for end users are offset by long-term partnerships between manufacturers and distributors, while regional differences in veterinary infrastructure influence testing adoption rates.

Recent Industry Insights

The Bovine Tuberculosis Diagnosis industry trends over the past 18 months reflect a surge in innovation driven by rising demand for rapid, accurate diagnostic solutions. Strategic partnerships have dominated the landscape, with key players like Zoetis and Thermo Fisher Scientific collaborating to integrate advanced molecular testing technologies into veterinary workflows. Mergers and acquisitions have accelerated, notably with bioMérieux acquiring a stake in a startup specializing in AI-driven pathogen detection, enhancing its portfolio of automated TB diagnostic tools. Regulatory shifts, including the USDA’s updated guidelines on herd testing protocols, have spurred adoption of Gamma Interferon and CFP-20/ESAT-6-based assays, prioritizing early outbreak detection. Meanwhile, enterprises are pivoting toward portable, point-of-care diagnostics, as seen in QIAGEN’s launch of a handheld PCR device for on-farm TB screening. Funding activity remains robust, with Series B rounds exceeding $50 million for companies like PathoFinder, which is scaling its multiplex nucleic acid tests. These developments underscore a market shift toward digital diagnostics, AI integration, and global One Health initiatives to mitigate zoonotic risks.

Analyst Overview

The Bovine Tuberculosis Diagnosis market outlook remains robust, driven by rising zoonotic disease concerns, regulatory mandates, and the critical role of livestock health in global food security. Market attractiveness is pronounced in high-prevalence regions, where rapid diagnostics are essential to mitigate economic losses. Competitive intensity is moderate, with key players prioritizing innovation in PCR-based assays and portable testing solutions to capture market share. Collaboration between diagnostics firms and government agencies is intensifying to address regulatory compliance and field accessibility.

Long-term growth is underpinned by advancements in AI-integrated diagnostic platforms and antigen-specific tests, enhancing accuracy and reducing turnaround times. The innovation landscape is dynamic, though fragmented, with startups focusing on cost-effective point-of-care tools. Demand-supply imbalances persist in low-income regions, though emerging manufacturers are expanding access. Key risks include cross-border cattle movement, underreporting in informal sectors, and slow adoption of novel technologies. Strategic R&D investments and public-private partnerships will be crucial to sustaining momentum in this high-stakes market.

11 items

1. Executive Summary

2. Bovine Tuberculosis Diagnosis Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Bovine Tuberculosis Diagnosis Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Bovine Tuberculosis Diagnosis Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Personal

6.1.2. Commercial

6.2. Global Bovine Tuberculosis Diagnosis Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Serological Tests

6.2.2. Molecular Diagnostic Tests

6.2.3. Traditional Tests

6.3. Global Bovine Tuberculosis Diagnosis Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Bovine Tuberculosis Diagnosis Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Bovine Tuberculosis Diagnosis Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Bovine Tuberculosis Diagnosis Market Competition by Key Manufacturers

8.1. Global Bovine Tuberculosis Diagnosis Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Bovine Tuberculosis Diagnosis: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. IDEXX Laboratories, Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. PBD Biotech Ltd.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Zoetis

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. IDvet

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Thermo Fisher Scientific Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Enfer Group

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. AsureQuality Australia Pty Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Bio-Rad Laboratories, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Bionote

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Bovine Tuberculosis Diagnosis Market

Figure 4: Global Bovine Tuberculosis Diagnosis Market: Drivers

Figure 5: Global Bovine Tuberculosis Diagnosis Market: Challenges

Figure 6: Global Bovine Tuberculosis Diagnosis Market: Trends

Figure 7: Global Bovine Tuberculosis Diagnosis Market: Opportunity

Figure 8: Global Bovine Tuberculosis Diagnosis Market: Restraint

Figure 9: Global Bovine Tuberculosis Diagnosis Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Bovine Tuberculosis Diagnosis Market Value (USD Million) By Region

Figure 15: Global Bovine Tuberculosis Diagnosis Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Bovine Tuberculosis Diagnosis Market Value (USD Million) By Region

Figure 23: Global Bovine Tuberculosis Diagnosis Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global Bovine Tuberculosis Diagnosis Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Bovine Tuberculosis Diagnosis Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Bovine Tuberculosis Diagnosis Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Bovine Tuberculosis Diagnosis Market Value (USD Million) By Region

Table 10: Global Bovine Tuberculosis Diagnosis Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Bovine Tuberculosis Diagnosis Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Bovine Tuberculosis Diagnosis Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Bovine Tuberculosis Diagnosis Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: IDEXX Laboratories, Inc. Basic Information And Sales Area

Table 31: IDEXX Laboratories, Inc.. Products Portfolio

Table 32: PBD Biotech Ltd. Basic Information And Sales Area

Table 33: PBD Biotech Ltd.. Products Portfolio

Table 34: Zoetis Basic Information And Sales Area

Table 35: Zoetis. Products Portfolio

Table 36: IDvet Basic Information And Sales Area

Table 37: IDvet. Products Portfolio

Table 38: Thermo Fisher Scientific Inc. Basic Information And Sales Area

Table 39: Thermo Fisher Scientific Inc.. Products Portfolio

Table 40: Enfer Group Basic Information And Sales Area

Table 41: Enfer Group. Products Portfolio

Table 42: AsureQuality Australia Pty Ltd. Basic Information And Sales Area

Table 43: AsureQuality Australia Pty Ltd.. Products Portfolio

Table 44: Bio-Rad Laboratories, Inc. Basic Information And Sales Area

Table 45: Bio-Rad Laboratories, Inc.. Products Portfolio

Table 46: Bionote Basic Information And Sales Area

Table 47: Bionote. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global Bovine Tuberculosis Diagnosis Market Value (USD Million) By Region

Table 53: Global Bovine Tuberculosis Diagnosis Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Bovine Tuberculosis Diagnosis Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	IDEXX Laboratories, Inc.; PBD Biotech Ltd.; Zoetis; IDvet; Thermo Fisher Scientific Inc.; Enfer Group; AsureQuality Australia Pty Ltd.; Bio-Rad Laboratories, Inc.; Bionote
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Bovine Tuberculosis Diagnosis Segmentation Breakdown7 items

Application

Personal

Commercial

Types

Serological Tests

Molecular Diagnostic Tests

Traditional Tests

Regional Insights

Loading chart…

Regional Drivers5 items

North America: Regulatory mandates (USDA), AI-driven diagnostics adoption

Europe: Cross-border data sharing, high farm biosecurity standards

Asia Pacific: Dairy modernization, rising FDI in agri-tech

Latin America: Brazil’s cattle exports, satellite tracking for herd monitoring

Middle East & Africa: GCC livestock investments, mobile diagnostic units

Competitive Landscape

Competitive Strategies6 items

IDEXX Laboratories, Inc.: Regional expansion in Asia-Pacific for livestock diagnostics

PBD Biotech Ltd.: Vertical integration to reduce supply chain costs in ELISA kits

Zoetis: Innovation pipeline for multiplex PCR-based TB detection platforms

Thermo Fisher Scientific Inc.: OEM tie-ups for diagnostic equipment distribution in emerging markets

Bio-Rad Laboratories, Inc.: Premium pricing for automated TB diagnostic systems

Enfer Group: Partnerships with veterinary labs for rapid lateral flow test adoption

Key Bovine Tuberculosis Diagnosis Companies9 items

IDEXX Laboratories, Inc.

PBD Biotech Ltd.

Zoetis

IDvet

Thermo Fisher Scientific Inc.

Enfer Group

AsureQuality Australia Pty Ltd.

Bio-Rad Laboratories, Inc.

Bionote

Market Ecosystem

Raw material/component suppliers — supply reagents, antigens, and consumables for diagnostic test production.

Diagnostic test manufacturers — develop and produce in vitro diagnostic assays and devices for TB detection.

Technology providers — license molecular, serological, or imaging platforms for diagnostic integration.

System integrators — assemble diagnostic kits, software, and hardware into validated testing solutions.

Distributors/channel partners — facilitate market access for veterinary labs and government agencies.

Veterinary diagnostic laboratories — perform TB testing, analyze samples, and issue reports for herd management.

Regulators/standards bodies — establish certification protocols, compliance frameworks, and approval pathways.

Recent Industry Insights

Analyst Overview

Table of Contents